Home/Filings/4/0000950170-25-034636
4//SEC Filing

Hughes Eric A 4

Accession 0000950170-25-034636

CIK 0000818686other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:11 PM ET

Size

11.4 KB

Accession

0000950170-25-034636

Insider Transaction Report

Form 4
Period: 2025-03-04
Hughes Eric A
See "Remarks"
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2025-03-04+23,25123,251 total
  • Sale

    Ordinary Shares

    2025-03-04$15.73/sh15,174$238,7578,077 total
  • Sale

    Ordinary Shares

    2025-03-05$15.91/sh8,077$128,5310 total
  • Exercise/Conversion

    Restricted Share Units

    2025-03-0423,25169,754 total
    Ordinary Shares (0 underlying)
Footnotes (6)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reportin person on November 15, 2024.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $16.015, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F6]Restricted share units were granted on March 4, 2024, with 23,251 vested on March 4, 2025, 23,251 vesting on each of March 4, 2026 and March 4, 2027, and 23,252 vesting on March 4, 2028.

Documents

1 file

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001938678

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:11 PM ET
Size
11.4 KB